W
Waiyee Kwong
Researcher at Stanford University
Publications - 7
Citations - 203
Waiyee Kwong is an academic researcher from Stanford University. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Fatty liver. The author has an hindex of 7, co-authored 7 publications receiving 116 citations.
Papers
More filters
Journal ArticleDOI
The Role of Vitamin E in the Treatment of NAFLD
Brandon J Perumpail,Andrew A. Li,Nimy John,Sandy Sallam,Neha D Shah,Waiyee Kwong,George Cholankeril,Donghee Kim,Aijaz Ahmed +8 more
TL;DR: The antioxidant, anti-inflammatory, and anti-apoptotic properties of vitamin E accompanied by ease-of-use and exceptional tolerability have made vitamin E a pragmatic therapeutic choice in non-diabetic patients with histologic evidence of NASH.
Journal ArticleDOI
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
Brandon J Perumpail,Andrew A. Li,Umair Iqbal,Sandy Sallam,Neha D Shah,Waiyee Kwong,George Cholankeril,Donghee Kim,Aijaz Ahmed +8 more
TL;DR: Preliminary data on several herbs have demonstrated promising antioxidant, anti-inflammatory,Anti-apoptotic, and anti-adipogenic properties that may help curtail the progression of NAFLD/NASH.
Journal ArticleDOI
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
Brandon J Perumpail,Andrew A. Li,Nimy John,Sandy Sallam,Neha D Shah,Waiyee Kwong,George Cholankeril,Donghee Kim,Aijaz Ahmed +8 more
TL;DR: Probiotics appear to be a promising option in the treatment of NAFLD and its subset NASH, and future research is necessary to assess the efficacy of probiotics in patients withNAFLD.
Journal ArticleDOI
Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD
Pratima Dibba,Andrew A. Li,Brandon J Perumpail,Nimy John,Sandy Sallam,Neha D Shah,Waiyee Kwong,George Cholankeril,Donghee Kim,Aijaz Ahmed +9 more
TL;DR: Treatment strategies have focused on lifestyle management of modifiable risk factors, namely weight, and on the optimization of the management of individual components of metabolic syndrome to effectively treat patients with NASH.
Journal ArticleDOI
Anti-Diabetic Medications for the Pharmacologic Management of NAFLD.
Rosann Cholankeril,Vikram Patel,Brandon J Perumpail,Eric R. Yoo,Umair Iqbal,Sandy Sallam,Neha D Shah,Waiyee Kwong,Donghee Kim,Aijaz Ahmed +9 more
TL;DR: Among anti-diabetic medications, only thiazolidinediones and glucagon-like peptide-1 receptor agonists demonstrate significant improvement in hepatic histology.